Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Senseonics
MedTech
Ascensia completes European launch of Eversense 6-month CGM
Fresh off the U.S. debut of Senseonics’ Eversense E3 CGM, distributor Ascensia Diabetes Care has completed the system's initial launch in Europe, too.
Andrea Park
Oct 10, 2022 10:22am
Senseonics' 180-day glucose sensor scores new European approval
Jun 16, 2022 11:55am
Ascensia Diabetes Care launches Eversense's 6-month CGM system
Apr 4, 2022 10:45am
Senseonics lands long-awaited FDA OK for 6-month CGM implant
Feb 11, 2022 9:42am
The top 10 Fierce Medtech stories of 2021
Dec 23, 2021 5:00am
ADA: Senseonics shows off accuracy for 180-day glucose sensor
Jun 28, 2021 11:44am